Drug class in one race
pan-RAS drugs for Non-Small Cell Lung Cancer
4 tracked pan-RAS drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the pan-RAS page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 31 Phase 21 Phase 1/21 preclinical / unstaged